| Biological Sciences | 2021-2025 | 10 | IR 2 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 832 | IR 4 | 99.81 |
| Cancer Research | Lifetime | 245 | IR 2 | 98.58 |
| Molecular Biology | 2021-2025 | 7 | IR 1 | 99.96 |
| Cancer Research | 2021-2025 | 1 | IR 1 | 99.94 |
| Immunology | 2021-2025 | 184 | IR 5 | 95.87 |
| Oncology | 2021-2025 | 570 | IR 5 | 91.75 |
| Genetics | 2021-2025 | 368 | IR 3 | 90.03 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 950 | IR 4 | 86.92 |
| Clinical Neurology | 2021-2025 | 450 | IR 3 | 83.84 |
| Hematology | 2021-2025 | 427 | IR 2 | 68.09 |
| Cancer-related molecular mechanisms research | Lifetime | 190 | IR 1 | 99.21 |
| Circular RNAs in diseases | Lifetime | 79 | IR 3 | 99.25 |
| MicroRNA in disease regulation | Lifetime | 201 | IR 4 | 99.16 |
| RNA modifications and cancer | Lifetime | 498 | IR 1 | 98.96 |
| RNA Research and Splicing | Lifetime | 580 | IR 1 | 98.37 |
| Extracellular vesicles in disease | Lifetime | 469 | IR 8 | 96.38 |
| RNA regulation and disease | Lifetime | 381 | IR 1 | 96.69 |
| Ferroptosis and cancer prognosis | Lifetime | 478 | IR 1 | 95.04 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 743 | IR 1 | 96.43 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 870 | IR 2 | 94.00 |
| Cancer-related molecular mechanisms research | 2021-2025 | 1 | IR 1 | 99.96 |
| MicroRNA in disease regulation | 2021-2025 | 1 | IR 1 | 99.94 |
| Circular RNAs in diseases | 2021-2025 | 1 | IR 1 | 99.94 |
| RNA Research and Splicing | 2021-2025 | 2 | IR 1 | 99.84 |
| RNA modifications and cancer | 2021-2025 | 6 | IR 1 | 99.91 |
| RNA regulation and disease | 2021-2025 | 3 | IR 2 | 99.61 |
| NF-κB Signaling Pathways | 2021-2025 | 1 | IR 1 | 98.04 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 8 | IR 1 | 98.17 |
| Extracellular vesicles in disease | 2021-2025 | 87 | IR 4 | 97.94 |
| interferon and immune responses | 2021-2025 | 64 | IR 1 | 95.99 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 134 | IR 1 | 95.31 |
| RNA Interference and Gene Delivery | 2021-2025 | 267 | IR 12 | 95.67 |
| Immune Cell Function and Interaction | 2021-2025 | 739 | IR 6 | 92.65 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 60 | IR 3 | 91.53 |
| Cancer-related gene regulation | 2021-2025 | 399 | IR 1 | 86.72 |
| Immune Response and Inflammation | 2021-2025 | 360 | IR 2 | 85.84 |
| Sperm and Testicular Function | 2021-2025 | 456 | IR 32 | 89.20 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 768 | IR 5 | 85.82 |
| Autophagy in Disease and Therapy | 2021-2025 | 626 | IR 6 | 86.27 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 300 | IR 7 | 83.67 |
| Mycobacterium research and diagnosis | 2021-2025 | 811 | IR 10 | 84.21 |
| FOXO transcription factor regulation | 2021-2025 | 59 | IR 3 | 73.91 |
| Hereditary Neurological Disorders | 2021-2025 | 313 | IR 5 | 76.52 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 685 | IR 27 | 70.19 |
| Molecular Biology Techniques and Applications | 2021-2025 | 991 | IR 4 | 67.58 |
| Nuts composition and effects | 2021-2025 | 796 | IR 37 | 53.99 |
